Angiodynamics reports fiscal 2021 second quarter financial results

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced financial results for the second quarter of fiscal year 2021, which ended november 30, 2020. “i am very pleased with our performance in the second quarter, as sales execution and continued expense management drove strong revenue and positive earnings,” commented jim clemmer, preside
ANGO Ratings Summary
ANGO Quant Ranking